Zelira Therapeutics’ commercialisation program to see launch of suite of new cannabinoid-based products over FY22

Zelira Therapeutics Ltd continues to focus on the expansion of commercialisation activities and revenue generation from its new clinically tested products, with the strategy expected to lead to the launch of a suite of new cannabinoid-based products over FY22. Commercialisation plans are focused on generating revenues from the multiple products it has launched into the… Continue reading Zelira Therapeutics’ commercialisation program to see launch of suite of new cannabinoid-based products over FY22

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of DraftKings Inc. f/k/a Diamond Eagle Acquisition Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 31, 2021 – DKNG

New York, New York–(Newsfile Corp. – August 31, 2021) – The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of DraftKings Inc. f/k/a Diamond Eagle Acquisition Corp. (“DraftKings Inc.”) (NASDAQ: DKNG) between December 23, 2019 and June 15, 2021. You are hereby notified… Continue reading SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of DraftKings Inc. f/k/a Diamond Eagle Acquisition Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 31, 2021 – DKNG